Research Topics
| R T ChenSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Challenges and controversies in immunization safetyR T Chen
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Infect Dis Clin North Am 15:21-39, viii. 2001..It also provides information on how various safety research is conducted, some of the concurrent challenges, and finally, some guidance on communicating with patients on vaccine risks...
The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USAR T Chen
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Bull World Health Organ 78:186-94. 2000....- Ukraine, 1992: first assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the Former Soviet UnionR T Chen
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Infect Dis 181:S178-83. 2000..It is concluded that initial priority for scarce resources for controlling this outbreak should be placed on vaccination of persons susceptible to diphtheria (e.g., adults) rather than revaccination of children... - Vaccine risks: real, perceived and unknownR T Chen
Vaccine Safety and Development Branch, National Immunization Program MS E61, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA
Vaccine 17:S41-6. 1999.... - Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Vaccine Safety Datalink TeamU D Parashar
Epidemic Intelligence Service, Viral Gastroenteritis Section, CDC, Atlanta, GA 30333, USA
Pediatr Infect Dis J 17:605-11. 1998..We used information from the Vaccine Safety Datalink (VSD) about approximately 1 million children enrolled in four health maintenance organizations to assess the morbidity from diarrhea and estimate the disease burden of rotavirus... - Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink TeamP Kramarz
Centers for Disease Control and Prevention, 1600 Clifton Road, MS E61, Atlanta, GA 30333, USA
Vaccine 18:2288-94. 2000..Vaccination coverage could be increased by taking advantage of all opportunities to vaccinate children with asthma whenever they make clinic visits in the fall and early winter... - Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitusF DeStefano
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30341 3724, USA
Pediatrics 108:E112. 2001..To evaluate suggested associations between childhood vaccinations, particularly against hepatitis B and Haemophilus influenzae type b, and risk of developing type 1 diabetes; and to determine whether timing of vaccination influences risk... - Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink TeamP Kramarz
Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Arch Fam Med 9:617-23. 2000..One reason for low influenza vaccine coverage among children with asthma may be concern that influenza vaccination may induce an exacerbation of asthma... - Addressing the challenges to immunization practice with an economic algorithm for vaccine selectionB G Weniger
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Vaccine 16:1885-97. 1998.... - Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccinationT Verstraeten
Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA, USA
Am J Epidemiol 154:1006-12. 2001..7 and 4.4, respectively) were comparable with those reported in the two studies. Linkage of VAERS to complimentary data sources may permit more timely postmarketing assessment of vaccine safety... - Does influenza vaccination prevent asthma exacerbations in children?P Kramarz
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Pediatr 138:306-10. 2001..The effectiveness of influenza vaccine in preventing influenza-related asthma exacerbations, however, is not known. We evaluated influenza vaccine effectiveness in protecting children against influenza-related asthma exacerbations... - A 'post-honeymoon period' measles outbreak in Muyinga sector, BurundiR T Chen
National Immunization Program MS E61 Centers for Disease Control and Prevention, Atlanta, GA 30333
Int J Epidemiol 23:185-93. 1994..Such outbreaks present new challenges to newly maturing immunization programmes in improving skills in surveillance, outbreak investigation, and public relations... - The incidence of Kawasaki syndrome in West Coast health maintenance organizationsE D Belay
Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Pediatr Infect Dis J 19:828-32. 2000..Kawasaki syndrome (KS) causes an acute vasculitis of unknown etiology. It is a leading cause of acquired heart disease of children in Japan and the United States... - Individual and community risks of measles and pertussis associated with personal exemptions to immunizationD R Feikin
Respiratory Diseases Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd, MS C23, Atlanta, GA 30333, USA
JAMA 284:3145-50. 2000..The risk of vaccine-preventable diseases among children who have philosophical and religious exemptions from immunization has been understudied... - Population-based study of rotavirus vaccination and intussusceptionP Kramarz
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
Pediatr Infect Dis J 20:410-6. 2001..0. The attributable risk was one case of intussusception per 11 073 children vaccinated. CONCLUSIONS: RRV-TV is associated with an increased risk of intussusception. The risk is greatest 3 to 7 days after the first vaccination dose... - National Immunization Information Hotline: Calls concerning adverse events, 1998-2000D A Gust
Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgi 30333, USA
J Health Commun 9:387-94. 2004.... - An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working GroupJ A Singleton
Vaccine Safety and Development Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Vaccine 17:2908-17. 1999..The acceptability, sensitivity and representativeness of VAERS are unknown. The study of vaccine safety is complicated by underreporting, erroneous reporting, frequent multiple exposures and multiple outcomes... - Epidemiology of autoimmune reactions induced by vaccinationR T Chen
Vaccine Safety and Development Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Autoimmun 16:309-18. 2001..Examples include the possible association of immunization and multiple sclerosis (and other demyelinating diseases), type 1 diabetes mellitus, Guillain-Barre Syndrome, idiopathic thrombocytopenic purpura, and rheumatoid arthritis... - Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccineW A Wattigney
Centers for Disease Control and Prevention, National Immunization Program, Atlanta, Georgia 30341 3717, USA
Pediatrics 107:E83. 2001..We compared VAERS reports after the receipt of IPV to reports after OPV in infants from 1991 through 1998. Comparisons included reports listing IPV and OPV coadministered with other vaccines... - Combination vaccines: postlicensure safety evaluationR T Chen
Vaccine Safety and Development Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Clin Infect Dis 33:S327-33. 2001..Only by investing in vaccine safety infrastructure at a level commensurate with investments in vaccine development can we hope to retain the public's confidence in immunization... - Autism and measles-mumps-rubella vaccination: controversy laid to rest?F DeStefano
National Center on Birth Defects and Developmental Disabilities, Atlanta, Georgia 30341 3724, USA
CNS Drugs 15:831-7. 2001..Currently, the weight of the available epidemiological and related evidence does not support a causal association between MMR vaccine, or any other vaccine or vaccine constituent, and autism... - Processes for obtaining nonmedical exemptions to state immunization lawsJ S Rota
Centers for Disease Control and Prevention, Measles Virus Section, Mail Stop C 22, 1600 Clifton Rd, Atlanta, GA 30333, USA
Am J Public Health 91:645-8. 2001..This study sought to determine the specific processes required for obtaining religious and philosophical exemptions to school immunization laws... - Advanced age a risk factor for illness temporally associated with yellow fever vaccinationM Martin
Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Emerg Infect Dis 7:945-51. 2001..For elderly travelers, the risk for severe illness and death due to YF infection should be balanced against the risk for systemic illness due to YF vaccine... - The National Immunization Information HotlineD A Gust
Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Health Commun 9:371-9. 2004.... - Principles of measles controlF T Cutts
Immunization Division, Centers for Disease Control, Atlanta, GA 30333
Bull World Health Organ 69:1-7. 1991....